In cells with EBV-associated GC (EBVaGC), overexpressed FTO removes the M6A modification from FOS mRNA via its demethylase function, leading to the natural degradation of FOS mRNA and a consequent decrease in its expression. The gene discussed is FOS; the disease is gastric cancer.